|
Volumn 48, Issue SUPPL. 4, 1997, Pages 107-114
|
Helicobacter pylori eradication in duodenal ulcer disease is cost-beneficial: A belgian model
|
Author keywords
Economics; Helicobacter pylori; Peptic ulcer
|
Indexed keywords
ANTIULCER AGENT;
OMEPRAZOLE;
RANITIDINE;
ARTICLE;
BELGIUM;
COST BENEFIT ANALYSIS;
DRUG ADMINISTRATION;
DRUG THERAPY;
DUODENUM ULCER;
ECONOMICS;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
MICROBIOLOGY;
PROBABILITY;
PROSPECTIVE STUDY;
ANTI-ULCER AGENTS;
BELGIUM;
COST-BENEFIT ANALYSIS;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY;
DUODENAL ULCER;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MARKOV CHAINS;
OMEPRAZOLE;
PROSPECTIVE STUDIES;
RANITIDINE;
|
EID: 0031218907
PISSN: 08675910
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (9)
|